TRILOGIQ (ALTRI.PA) Fundamental Analysis & Valuation

EPA:ALTRI • FR0010397901

Current stock price

5.1 EUR
-0.15 (-2.86%)
Last:

This ALTRI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALTRI.PA Profitability Analysis

1.1 Basic Checks

  • ALTRI had negative earnings in the past year.
  • In the past year ALTRI had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ALTRI reported negative net income in multiple years.
  • Of the past 5 years ALTRI 4 years had a positive operating cash flow.
ALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 2M -2M 4M -4M -6M -8M

1.2 Ratios

  • ALTRI has a Return On Assets of -1.02%. This is in the lower half of the industry: ALTRI underperforms 75.76% of its industry peers.
  • ALTRI has a worse Return On Equity (-1.12%) than 72.73% of its industry peers.
  • ALTRI has a Return On Invested Capital of 0.00%. This is in the lower half of the industry: ALTRI underperforms 77.78% of its industry peers.
Industry RankSector Rank
ROA -1.02%
ROE -1.12%
ROIC 0%
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTRI.PA Yearly ROA, ROE, ROICALTRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 -5 -10 -15 -20

1.3 Margins

  • ALTRI's Profit Margin has improved in the last couple of years.
  • ALTRI's Operating Margin of 0.01% is on the low side compared to the rest of the industry. ALTRI is outperformed by 78.79% of its industry peers.
  • In the last couple of years the Operating Margin of ALTRI has grown nicely.
  • With an excellent Gross Margin value of 62.66%, ALTRI belongs to the best of the industry, outperforming 85.86% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALTRI has grown nicely.
Industry RankSector Rank
OM 0.01%
PM (TTM) N/A
GM 62.66%
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
ALTRI.PA Yearly Profit, Operating, Gross MarginsALTRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 20 -20 40 60

9

2. ALTRI.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALTRI is destroying value.
  • ALTRI has about the same amout of shares outstanding than it did 1 year ago.
  • ALTRI has about the same amout of shares outstanding than it did 5 years ago.
  • ALTRI has a better debt/assets ratio than last year.
ALTRI.PA Yearly Shares OutstandingALTRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2022 2023 2024 2025 1M 2M 3M
ALTRI.PA Yearly Total Debt VS Total AssetsALTRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 5.68 indicates that ALTRI is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of ALTRI (5.68) is better than 94.95% of its industry peers.
  • ALTRI has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
  • ALTRI's Debt to FCF ratio of 0.01 is amongst the best of the industry. ALTRI outperforms 98.99% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that ALTRI is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.00, ALTRI belongs to the top of the industry, outperforming 96.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 5.68
ROIC/WACC0
WACC8.04%
ALTRI.PA Yearly LT Debt VS Equity VS FCFALTRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 11.26 indicates that ALTRI has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 11.26, ALTRI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • ALTRI has a Quick Ratio of 9.97. This indicates that ALTRI is financially healthy and has no problem in meeting its short term obligations.
  • ALTRI has a better Quick ratio (9.97) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 11.26
Quick Ratio 9.97
ALTRI.PA Yearly Current Assets VS Current LiabilitesALTRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2022 2023 2024 2025 10M 20M 30M 40M

0

3. ALTRI.PA Growth Analysis

3.1 Past

  • ALTRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -116.31%.
  • Measured over the past years, ALTRI shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.14% on average per year.
  • Looking at the last year, ALTRI shows a very negative growth in Revenue. The Revenue has decreased by -12.41% in the last year.
  • ALTRI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.29% yearly.
EPS 1Y (TTM)-116.31%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-111.11%
Revenue 1Y (TTM)-12.41%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-10.72%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTRI.PA Yearly Revenue VS EstimatesALTRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALTRI.PA Yearly EPS VS EstimatesALTRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1

2

4. ALTRI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALTRI. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 14.15, the valuation of ALTRI can be described as correct.
  • ALTRI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALTRI is cheaper than 65.66% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, ALTRI is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.15
ALTRI.PA Price Earnings VS Forward Price EarningsALTRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • ALTRI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 18.2
EV/EBITDA -25.03
ALTRI.PA Per share dataALTRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ALTRI.PA Dividend Analysis

5.1 Amount

  • ALTRI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALTRI.PA Fundamentals: All Metrics, Ratios and Statistics

TRILOGIQ

EPA:ALTRI (4/29/2026, 7:00:00 PM)

5.1

-0.15 (-2.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Industry Strength46.62
Industry Growth66
Earnings (Last)07-24
Earnings (Next)N/A
Inst Owners1.72%
Inst Owner ChangeN/A
Ins Owners76.77%
Ins Owner ChangeN/A
Market Cap19.07M
Revenue(TTM)21.90M
Net Income(TTM)-421.00K
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.15
P/S 0.87
P/FCF 18.2
P/OCF 14.74
P/B 0.51
P/tB 0.51
EV/EBITDA -25.03
EPS(TTM)-0.11
EYN/A
EPS(NY)0.36
Fwd EY7.07%
FCF(TTM)0.28
FCFY5.49%
OCF(TTM)0.35
OCFY6.78%
SpS5.86
BVpS10.07
TBVpS10.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.02%
ROE -1.12%
ROCE 0.01%
ROIC 0%
ROICexc 0.01%
ROICexgc 0.01%
OM 0.01%
PM (TTM) N/A
GM 62.66%
FCFM 4.79%
ROA(3y)1.54%
ROA(5y)N/A
ROE(3y)1.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y31.78%
ROICexgc growth 5YN/A
ROICexc growth 3Y31.69%
ROICexc growth 5YN/A
OM growth 3Y17.04%
OM growth 5YN/A
PM growth 3Y25.71%
PM growth 5YN/A
GM growth 3Y1.99%
GM growth 5Y12.3%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.01
Cap/Depr 22.63%
Cap/Sales 1.12%
Interest Coverage 250
Cash Conversion 118.83%
Profit Quality N/A
Current Ratio 11.26
Quick Ratio 9.97
Altman-Z 5.68
F-Score4
WACC8.04%
ROIC/WACC0
Cap/Depr(3y)38.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-116.31%
EPS 3Y29.14%
EPS 5YN/A
EPS Q2Q%-111.11%
EPS Next Y-2.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.41%
Revenue growth 3Y2.81%
Revenue growth 5Y-0.29%
Sales Q2Q%-10.72%
Revenue Next Year5.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-99.88%
EBIT growth 3Y20.32%
EBIT growth 5YN/A
EBIT Next Year187.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-58.25%
FCF growth 3YN/A
FCF growth 5Y-4.81%
OCF growth 1Y-53.62%
OCF growth 3YN/A
OCF growth 5Y-3.83%

TRILOGIQ / ALTRI.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TRILOGIQ (ALTRI.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALTRI.PA.


Can you provide the valuation status for TRILOGIQ?

ChartMill assigns a valuation rating of 2 / 10 to TRILOGIQ (ALTRI.PA). This can be considered as Overvalued.


What is the profitability of ALTRI stock?

TRILOGIQ (ALTRI.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for ALTRI stock?

The financial health rating of TRILOGIQ (ALTRI.PA) is 9 / 10.